# Dexmedetomidine on Tourniquet Induced -Systemic Effects

> **NCT04307290** · PHASE4 · COMPLETED · sponsor: **Wonkwang University Hospital** · enrollment: 80 (actual)

## Conditions studied

- Arthropathy of Knee
- Spinal Anesthesia
- Tourniquet
- Ischemia-reperfusion Injury

## Interventions

- **DRUG:** Dexmedetomidine Hydrochloride, or Saline

## Key facts

- **NCT ID:** NCT04307290
- **Lead sponsor:** Wonkwang University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-03
- **Primary completion:** 2020-02-10
- **Final completion:** 2020-03-05
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04307290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04307290, "Dexmedetomidine on Tourniquet Induced -Systemic Effects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04307290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*